The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 564.00
Bid: 561.00
Ask: 564.00
Change: 6.00 (1.08%)
Spread: 3.00 (0.535%)
Open: 555.00
High: 564.00
Low: 553.00
Prev. Close: 558.00
BAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

28 Jan 2020 07:00

RNS Number : 0670B
Barr(A.G.) PLC
28 January 2020
 

IMMEDIATE RELEASE 28 January 2020

A.G. BARR p.l.c.

("A.G. BARR")

Trading Update 

A.G. BARR p.l.c., which produces and markets some of the UK's leading drinks brands, including IRN-BRU, Rubicon, Strathmore and Funkin, today announces a trading update in respect of the financial year ended 25 January 2020.

 

Adjusted profit before tax1 performance is expected to be at the top end of current market expectations, just ahead of £37m.

Revenue for the period is expected to be c. £255m (2018 : £279m).

As previously communicated, we faced a combination of challenging trading conditions during the year, particularly across the summer period. In addition, following our 2018 volume-led strategy, across 2019 we adjusted our promotional and pricing position to align more closely with the market. While this had an expected impact on volume, it has delivered an increase in average realised price, re-establishing our consumer pricing position.

Our Rockstar and Rubicon recovery plans are now being implemented, IRN-BRU has returned to growth in the final quarter and Funkin continues to perform strongly.

We have completed the first phase of our business re-engineering programme. The associated exceptional costs in the period of £1.5 - £2m are expected to be almost entirely offset by a one-off exceptional gain related to the removal of a wind turbine at our Cumbernauld site.2

Our business remains strongly cash generative and, as planned, our £30m share repurchase programme completed during the period. Our balance sheet remains robust.

The external landscape remains challenging, however we exit the year with encouraging trading momentum which we expect to continue into 2020.

Commenting on the results, Roger White, Chief Executive, said:

"Our focus remains the delivery of long-term value growth. We are taking action to reset our business and we enter the new financial year with confidence and a strong trading plan."

 

A.G. BARR intends to announce its full year financial results on 24 March 2020.

 

For further information, please contact:

A.G. BARR Tel: 0330 390 3900 Roger White, Chief Executive Stuart Lorimer, Finance Director

Instinctif Partners Tel: 020 7457 2020 Justine Warren 

Matthew Smallwood

 

1 Note : Adjusted profit before tax defined as profit before tax and exceptionals.

2 Note : For a number of years a wind turbine has been in operation at our Cumbernauld site. This turbine has now been removed to facilitate the construction and operation of additional large scale wind energy projects in Scotland, thereby supporting the achievement of Scottish climate change targets.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAXFXAFKEEFA
Date   Source Headline
23rd Apr 20249:17 amRNSAnnual Financial Report
15th Apr 20242:59 pmRNSDirector/PDMR Shareholding
9th Apr 20243:46 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 20243:36 pmRNSDirector/PDMR Shareholding
9th Apr 20241:05 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 202412:50 pmRNSDirector/PDMR Shareholding
5th Apr 20242:26 pmRNSDirector/PDMR Shareholding
2nd Apr 202411:15 amRNSDirector/PDMR Shareholding
28th Mar 202410:10 amRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSDirectorate changes announcement
26th Mar 20247:00 amRNSFinal Results
14th Mar 20243:01 pmRNSBusiness reorganisation
11th Mar 20248:39 amRNSDirector/PDMR Shareholding
27th Feb 20241:47 pmRNSHolding(s) in Company
8th Feb 20242:03 pmRNSDirector/PDMR Shareholding - Replacement
8th Feb 20241:51 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBoard succession announcement
1st Feb 20247:00 amRNSTrading Update
16th Jan 20247:00 amRNSNotice of Trading Update
9th Jan 20241:36 pmRNSDirector/PDMR Shareholding
14th Dec 20239:22 amRNSDirector Declaration
11th Dec 20239:47 amRNSDirector/PDMR Shareholding
17th Nov 202310:13 amRNSUpdate statement on 2023 AGM Voting Results
8th Nov 202310:45 amRNSDirector/PDMR Shareholding
3rd Nov 20233:44 pmRNSDirector/PDMR Shareholding
30th Oct 20233:10 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSAcquisition of tropical drinks brand Rio
10th Oct 20238:21 amRNSDirector/PDMR Shareholding
26th Sep 20237:00 amRNSInterim Results
11th Sep 20239:08 amRNSDirector/PDMR Shareholding
8th Aug 20232:07 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSBoard succession announcement
1st Aug 20237:00 amRNSTrading update for the 26 weeks ended 30 July 2023
10th Jul 202312:42 pmRNSDirector/PDMR Shareholding
14th Jun 20239:40 amRNSDirector/PDMR Shareholding
13th Jun 20239:24 amRNSDirector/PDMR Shareholding - Replacement
13th Jun 20238:59 amRNSDirector/PDMR Shareholding
13th Jun 20238:55 amRNSDirector/PDMR Shareholding
12th Jun 20233:59 pmRNSDirector/PDMR Shareholding
8th Jun 20231:02 pmRNSDirector/PDMR Shareholding
26th May 20231:57 pmRNSDirectorate Change
26th May 20231:55 pmRNSResult of AGM
10th May 20239:25 amRNSDirector/PDMR Shareholding
4th May 20239:22 amRNSDirector Declaration
25th Apr 20239:14 amRNSAnnual Financial Report / Notice of AGM
12th Apr 20233:31 pmRNSDirector/PDMR Shareholding
12th Apr 202311:23 amRNSDirector/PDMR Shareholding
11th Apr 202310:07 amRNSDirector/PDMR Shareholding
30th Mar 202310:24 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSBoard succession update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.